PRGO
Perrigo Company plc
Price Chart
Latest Quote
$10.25
+0.09 (+0.89%)
Current Price
| Previous Close | $10.16 |
| Open | $10.05 |
| Day High | $10.25 |
| Day Low | $9.82 |
| Volume | 5,131,254 |
Stock Information
| Quarterly Dividend / Yield | $1.16 / 11.32% |
| Shares Outstanding | 138.37M |
| Quarterly Dividend Yield | 11.32% |
| Quarterly Dividend | $1.16 |
| Total Debt | $3.83B |
| Cash Equivalents | $357.20M |
| Revenue | $4.18B |
| Net Income | $-1.79B |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.42B |
| EPS (TTM) | $-12.93 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.89B |
| Sales | $4.18B |
| Income | $-1.79B |
| Book/sh | $18.09 |
| Cash/sh | $2.58 |
| Employees | 8K |
Financial Ratios
| Quick Ratio | 1.09 |
| Current Ratio | 2.72 |
| Debt/Eq | 153.22 |
Returns & Margins
| ROA | 2.09% |
| ROE | -52.23% |
| Gross Margin | 34.17% |
| Operating Margin | 3.47% |
| Profit Margin | -43.50% |
Ownership
| Insider Ownership | 0.39% |
| Institutional Ownership | 116.52% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 4.34 |
| PEG | 1.14 |
| P/S | 0.34 |
| P/B | 0.57 |
Analyst Data
| Recommendation | buy |
| Target Price | $16.50 |
Technical Indicators
| SMA20 | $10.82 |
| SMA50 | $10.99 |
| SMA200 | $13.97 |
| RSI | 38.44 |
| ATR | 0.5764 |
| Shares Float | 137.62M |
| Short Float | 16.73% |
| Short Ratio | 5.95 |
| Volatility | 0.52 |
| Rel Volume | 1.56 |
Performance History
| Week | -5.96% |
| Month | -0.88% |
| Quarter | +8.98% |
| 6 Months | -17.42% |
| YTD | -22.59% |
| Year | -58.56% |
| 3 Years | -64.50% |
| 5 Years | -73.91% |
| 10 Years | -86.24% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $10.25 | 5,131,300 |
| 2026-06-17 | $10.16 | 3,162,200 |
| 2026-06-16 | $10.67 | 2,297,000 |
| 2026-06-15 | $10.70 | 2,725,900 |
| 2026-06-12 | $10.99 | 3,243,200 |
| 2026-06-11 | $10.90 | 3,561,400 |
| 2026-06-10 | $11.17 | 5,613,400 |
| 2026-06-09 | $11.18 | 5,207,400 |
| 2026-06-08 | $11.61 | 5,013,000 |
| 2026-06-05 | $10.83 | 2,999,200 |
| 2026-06-04 | $10.67 | 2,569,100 |
| 2026-06-03 | $10.46 | 2,338,500 |
| 2026-06-02 | $10.46 | 3,504,500 |
| 2026-06-01 | $10.76 | 2,643,400 |
| 2026-05-29 | $11.05 | 2,351,700 |
| 2026-05-28 | $11.15 | 2,366,700 |
| 2026-05-27 | $10.88 | 3,417,100 |
| 2026-05-26 | $10.53 | 3,060,900 |
| 2026-05-22 | $10.94 | 2,283,500 |
| 2026-05-21 | $11.06 | 2,240,400 |
| 2026-05-20 | $10.88 | 2,417,900 |
| 2026-05-19 | $10.34 | 2,530,600 |
About Perrigo Company plc
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
đ° Latest News
FDA Seeks Updated Labeling for Testosterone Therapies
MT Newswires âĸ 2026-06-18T21:56:31ZJim Cramer on Perrigo Comapny: âThis Is a Value Trapâ
Insider Monkey âĸ 2026-06-17T16:53:55Z
Perrigo Leadership Shakeup Puts Governance And Long Term Strategy In Focus
Simply Wall St. âĸ 2026-06-09T04:32:05Z
Perrigo CEO Ousted Over Personal Conduct
The Wall Street Journal âĸ 2026-06-08T21:11:00Z
Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?
Zacks âĸ 2026-06-05T15:30:27Z
Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y
Zacks âĸ 2026-05-07T16:56:00Z
Assessing Perrigo (PRGO) Valuation After Weak Q1 Results And Lowered Guidance
Simply Wall St. âĸ 2026-05-07T14:21:33Z
Perrigo Company plc Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T12:30:00Z
Perrigo (PRGO) Q1 Earnings Beat Estimates
Zacks âĸ 2026-05-06T11:45:05Z
How Investors Are Reacting To Perrigo (PRGO) Dermacosmetics Sale, Dividend Payout, And Infant Formula Strains
Simply Wall St. âĸ 2026-05-05T23:24:29Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,758,600,000 | $2,830,700,000 | $2,975,200,000 | $2,996,200,000 |
| Cost Of Revenue | $2,758,600,000 | $2,830,700,000 | $2,975,200,000 | $2,996,200,000 |
| Total Revenue | $4,253,100,000 | $4,373,400,000 | $4,655,600,000 | $4,451,600,000 |
| Operating Revenue | $4,253,100,000 | $4,373,400,000 | $4,655,600,000 | $4,451,600,000 |
| Expenses | ||||
| Interest Expense | $162,500,000 | $187,800,000 | $173,800,000 | $156,000,000 |
| Total Expenses | $3,940,300,000 | $4,061,500,000 | $4,371,500,000 | $4,330,200,000 |
| Other Income Expense | $-1,448,200,000 | $-204,800,000 | $-118,600,000 | $-104,500,000 |
| Other Non Operating Income Expenses | $-13,200,000 | $900,000 | $10,400,000 | $-53,100,000 |
| Net Non Operating Interest Income Expense | $-162,500,000 | $-187,800,000 | $-173,800,000 | $-156,000,000 |
| Interest Expense Non Operating | $162,500,000 | $187,800,000 | $173,800,000 | $156,000,000 |
| Operating Expense | $1,181,700,000 | $1,230,800,000 | $1,396,300,000 | $1,334,000,000 |
| Other Operating Expenses | $30,500,000 | $6,000,000 | $-800,000 | $800,000 |
| Selling And Marketing Expense | $619,900,000 | $644,600,000 | $752,300,000 | $697,800,000 |
| General And Administrative Expense | $435,900,000 | $468,000,000 | $522,300,000 | $512,300,000 |
| Total Other Finance Cost | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,402,300,000 | $-160,700,000 | $-4,400,000 | $-130,900,000 |
| Net Interest Income | $-162,500,000 | $-187,800,000 | $-173,800,000 | $-156,000,000 |
| Normalized Income | $-268,650,000 | $1,803,000 | $97,510,000 | $-82,532,600 |
| Net Income From Continuing And Discontinued Operation | $-1,425,400,000 | $-171,800,000 | $-12,700,000 | $-140,600,000 |
| Total Operating Income As Reported | $-1,122,200,000 | $112,900,000 | $151,900,000 | $78,900,000 |
| Net Income Common Stockholders | $-1,425,400,000 | $-171,800,000 | $-12,700,000 | $-140,600,000 |
| Net Income | $-1,425,400,000 | $-171,800,000 | $-12,700,000 | $-140,600,000 |
| Net Income Including Noncontrolling Interests | $-1,425,400,000 | $-171,800,000 | $-12,700,000 | $-140,600,000 |
| Net Income Discontinuous Operations | $-23,100,000 | $-11,100,000 | $-8,300,000 | $-9,700,000 |
| Net Income Continuous Operations | $-1,402,300,000 | $-160,700,000 | $-4,400,000 | $-130,900,000 |
| Pretax Income | $-1,297,900,000 | $-80,700,000 | $-8,300,000 | $-139,100,000 |
| Special Income Charges | $-1,435,000,000 | $-205,700,000 | $-129,000,000 | $-51,400,000 |
| Operating Income | $312,800,000 | $311,900,000 | $284,100,000 | $121,400,000 |
| Gross Profit | $1,494,500,000 | $1,542,700,000 | $1,680,400,000 | $1,455,400,000 |
| Per Share | ||||
| Diluted EPS | $-10.29 | $-1.25 | $-0.09 | $-1.04 |
| Basic EPS | $-10.29 | $-1.25 | $-0.09 | $-1.04 |
| Other | ||||
| Tax Effect Of Unusual Items | $-301,350,000 | $-43,197,000 | $-27,090,000 | $-3,032,600 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $637,100,000 | $638,700,000 | $654,000,000 | $406,900,000 |
| Total Unusual Items | $-1,435,000,000 | $-205,700,000 | $-129,000,000 | $-51,400,000 |
| Total Unusual Items Excluding Goodwill | $-1,435,000,000 | $-205,700,000 | $-129,000,000 | $-51,400,000 |
| Reconciled Depreciation | $337,500,000 | $325,900,000 | $359,500,000 | $338,600,000 |
| EBITDA (Bullshit earnings) | $-797,900,000 | $433,000,000 | $525,000,000 | $355,500,000 |
| EBIT | $-1,135,400,000 | $107,100,000 | $165,500,000 | $16,900,000 |
| Diluted Average Shares | $138,500,000 | $137,400,000 | $135,300,000 | $134,500,000 |
| Basic Average Shares | $138,500,000 | $137,400,000 | $135,300,000 | $134,500,000 |
| Diluted NI Availto Com Stockholders | $-1,425,400,000 | $-171,800,000 | $-12,700,000 | $-140,600,000 |
| Tax Provision | $104,400,000 | $80,000,000 | $-3,900,000 | $-8,200,000 |
| Write Off | $1,363,100,000 | $88,900,000 | $90,000,000 | $0 |
| Restructuring And Mergern Acquisition | $71,900,000 | $110,100,000 | $42,200,000 | $42,500,000 |
| Research And Development | $95,400,000 | $112,200,000 | $122,500,000 | $123,100,000 |
| Selling General And Administration | $1,055,800,000 | $1,112,600,000 | $1,274,600,000 | $1,210,100,000 |
| Other Gand A | $435,900,000 | $468,000,000 | $522,300,000 | $512,300,000 |
| Other Special Charges | - | $6,700,000 | $-3,200,000 | $8,900,000 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,470,700,000 | $-1,429,700,000 | $-1,747,300,000 | $-1,937,100,000 |
| Total Assets | $8,535,200,000 | $9,647,700,000 | $10,809,100,000 | $11,017,300,000 |
| Total Non Current Assets | $5,737,800,000 | $7,165,800,000 | $7,976,200,000 | $8,297,400,000 |
| Other Non Current Assets | $261,800,000 | $318,600,000 | $335,200,000 | $367,700,000 |
| Non Current Deferred Assets | $3,300,000 | $5,100,000 | $25,800,000 | $7,100,000 |
| Non Current Deferred Taxes Assets | $3,300,000 | $5,100,000 | $25,800,000 | $7,100,000 |
| Goodwill And Other Intangible Assets | $4,406,200,000 | $5,749,100,000 | $6,515,200,000 | $6,779,200,000 |
| Other Intangible Assets | $2,356,100,000 | $2,428,900,000 | $2,986,100,000 | $3,288,800,000 |
| Current Assets | $2,797,400,000 | $2,481,900,000 | $2,832,900,000 | $2,719,900,000 |
| Other Current Assets | $231,400,000 | $199,000,000 | $201,100,000 | $271,800,000 |
| Assets Held For Sale Current | $272,600,000 | $0 | - | $0 |
| Inventory | $1,149,000,000 | $1,081,800,000 | $1,140,900,000 | $1,150,300,000 |
| Receivables | $612,800,000 | $642,300,000 | $739,600,000 | $697,100,000 |
| Accounts Receivable | $612,800,000 | $642,300,000 | $739,600,000 | $697,100,000 |
| Allowance For Doubtful Accounts Receivable | $-6,500,000 | $-7,400,000 | $-7,800,000 | $-6,800,000 |
| Gross Accounts Receivable | $619,300,000 | $649,700,000 | $747,400,000 | $703,900,000 |
| Cash Cash Equivalents And Short Term Investments | $531,600,000 | $558,800,000 | $751,300,000 | $600,700,000 |
| Cash And Cash Equivalents | $531,600,000 | $558,800,000 | $751,300,000 | $600,700,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $3,108,600,000 | $3,059,300,000 | $3,322,100,000 | $3,505,900,000 |
| Total Debt | $3,640,200,000 | $3,618,100,000 | $4,073,400,000 | $4,106,600,000 |
| Long Term Debt And Capital Lease Obligation | $3,603,600,000 | $3,581,700,000 | $3,632,800,000 | $4,070,400,000 |
| Long Term Debt | $3,603,600,000 | $3,581,700,000 | $3,632,800,000 | $4,070,400,000 |
| Current Debt And Capital Lease Obligation | $36,600,000 | $36,400,000 | $440,600,000 | $36,200,000 |
| Current Debt | $36,600,000 | $36,400,000 | $440,600,000 | $36,200,000 |
| Other Current Borrowings | - | - | - | $36,200,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $5,599,700,000 | $5,328,300,000 | $6,041,200,000 | $6,175,200,000 |
| Total Non Current Liabilities Net Minority Interest | $4,586,800,000 | $4,284,100,000 | $4,454,900,000 | $5,061,600,000 |
| Other Non Current Liabilities | $814,300,000 | $499,200,000 | $559,800,000 | $623,000,000 |
| Non Current Deferred Liabilities | $168,900,000 | $203,200,000 | $262,300,000 | $368,200,000 |
| Non Current Deferred Taxes Liabilities | $168,900,000 | $203,200,000 | $262,300,000 | $368,200,000 |
| Current Liabilities | $1,012,900,000 | $1,044,200,000 | $1,586,300,000 | $1,113,600,000 |
| Other Current Liabilities | $26,800,000 | - | - | $101,300,000 |
| Payables And Accrued Expenses | $949,500,000 | $1,007,800,000 | $1,145,700,000 | $1,077,400,000 |
| Payables | $495,300,000 | $512,600,000 | $519,800,000 | $551,700,000 |
| Total Tax Payable | $20,800,000 | $17,400,000 | $42,100,000 | $14,400,000 |
| Income Tax Payable | $20,800,000 | $17,400,000 | $42,100,000 | $14,400,000 |
| Accounts Payable | $474,500,000 | $495,200,000 | $477,700,000 | $537,300,000 |
| Liabilities Heldfor Sale Non Current | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $2,935,500,000 | $4,319,400,000 | $4,767,900,000 | $4,842,100,000 |
| Total Equity Gross Minority Interest | $2,935,500,000 | $4,319,400,000 | $4,767,900,000 | $4,842,100,000 |
| Stockholders Equity | $2,935,500,000 | $4,319,400,000 | $4,767,900,000 | $4,842,100,000 |
| Gains Losses Not Affecting Retained Earnings | $4,800,000 | $-162,400,000 | $10,700,000 | $-27,000,000 |
| Other Equity Adjustments | $4,800,000 | $-162,400,000 | $10,700,000 | $-27,000,000 |
| Retained Earnings | $-3,677,500,000 | $-2,252,100,000 | $-2,080,300,000 | $-2,067,600,000 |
| Other | ||||
| Preferred Shares Number | $10,000 | $10,000 | $10,000 | $10,000 |
| Ordinary Shares Number | $137,624,009 | $136,427,804 | $135,506,489 | $134,700,000 |
| Share Issued | $137,624,009 | $136,427,804 | $135,506,489 | $134,700,000 |
| Tangible Book Value | $-1,470,700,000 | $-1,429,700,000 | $-1,747,300,000 | $-1,937,100,000 |
| Invested Capital | $6,575,700,000 | $7,937,500,000 | $8,841,300,000 | $8,948,700,000 |
| Working Capital | $1,784,500,000 | $1,437,700,000 | $1,246,600,000 | $1,606,300,000 |
| Total Capitalization | $6,539,100,000 | $7,901,100,000 | $8,400,700,000 | $8,912,500,000 |
| Capital Stock | $6,608,200,000 | $6,733,900,000 | $6,837,500,000 | $6,936,700,000 |
| Common Stock | $6,608,200,000 | $6,733,900,000 | $6,837,500,000 | $6,936,700,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Accrued Expenses | $454,200,000 | $495,200,000 | $625,900,000 | $525,700,000 |
| Goodwill | $2,050,100,000 | $3,320,200,000 | $3,529,100,000 | $3,490,400,000 |
| Net PPE | $1,066,500,000 | $1,093,000,000 | $1,100,000,000 | $1,143,400,000 |
| Accumulated Depreciation | $-1,259,500,000 | $-1,141,600,000 | $-1,072,400,000 | $-990,000,000 |
| Gross PPE | $2,326,000,000 | $2,234,600,000 | $2,172,400,000 | $2,133,400,000 |
| Other Properties | $167,800,000 | $175,200,000 | $183,600,000 | $217,100,000 |
| Machinery Furniture Equipment | $1,465,500,000 | $1,380,200,000 | $1,326,900,000 | $1,271,700,000 |
| Buildings And Improvements | $639,400,000 | $624,300,000 | $611,300,000 | $593,000,000 |
| Land And Improvements | $53,300,000 | $54,900,000 | $50,600,000 | $51,600,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $685,600,000 | $627,100,000 | $646,800,000 | $620,300,000 |
| Work In Process | $259,400,000 | $233,300,000 | $241,900,000 | $262,200,000 |
| Raw Materials | $204,000,000 | $221,400,000 | $252,200,000 | $267,800,000 |
| Treasury Shares Number | - | - | $0 | - |
| Capital Lease Obligations | - | - | - | $217,900,000 |
| Long Term Capital Lease Obligation | - | - | - | $189,500,000 |
| Current Capital Lease Obligation | - | - | - | $28,400,000 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $145,100,000 | $244,600,000 | $303,800,000 | $210,900,000 |
| Operating Activities | ||||
| Operating Cash Flow | $238,500,000 | $362,900,000 | $405,500,000 | $307,300,000 |
| Cash Flow From Continuing Operating Activities | $238,500,000 | $362,900,000 | $405,500,000 | $307,300,000 |
| Operating Gains Losses | $1,600,000 | $21,100,000 | $-4,100,000 | $35,500,000 |
| Investing Activities | ||||
| Capital Expenditure | $-93,400,000 | $-118,300,000 | $-101,700,000 | $-96,400,000 |
| Investing Cash Flow | $-75,400,000 | $78,800,000 | $-77,500,000 | $-1,958,600,000 |
| Cash Flow From Continuing Investing Activities | $-75,400,000 | $78,800,000 | $-77,500,000 | $-1,958,600,000 |
| Net Other Investing Changes | $-2,000,000 | $24,600,000 | $4,400,000 | $25,500,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-220,500,000 | $-611,000,000 | $-187,200,000 | $421,600,000 |
| Cash Flow From Continuing Financing Activities | $-220,500,000 | $-611,000,000 | $-187,200,000 | $421,600,000 |
| Net Other Financing Charges | $-26,400,000 | $-20,700,000 | $-7,300,000 | $-52,700,000 |
| Cash Dividends Paid | $-159,300,000 | $-152,500,000 | $-149,700,000 | $-142,400,000 |
| Common Stock Dividend Paid | - | - | $-149,700,000 | $-142,400,000 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Issuance Of Capital Stock | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-34,800,000 | $-1,529,000,000 | $-325,300,000 | $-970,600,000 |
| Issuance Of Debt | $0 | $1,091,200,000 | $295,100,000 | $1,587,300,000 |
| Interest Paid Supplemental Data | $202,000,000 | $251,400,000 | $276,900,000 | $217,000,000 |
| Income Tax Paid Supplemental Data | $98,900,000 | $155,700,000 | $107,500,000 | $100,200,000 |
| End Cash Position | $531,600,000 | $558,800,000 | $751,300,000 | $600,700,000 |
| Other Cash Adjustment Outside Changein Cash | $-2,300,000 | $0 | $0 | $14,400,000 |
| Beginning Cash Position | $558,800,000 | $751,300,000 | $600,700,000 | $1,864,900,000 |
| Effect Of Exchange Rate Changes | $32,500,000 | $-23,200,000 | $9,800,000 | $-48,900,000 |
| Changes In Cash | $-57,400,000 | $-169,300,000 | $140,800,000 | $-1,229,700,000 |
| Net Issuance Payments Of Debt | $-34,800,000 | $-437,800,000 | $-30,200,000 | $616,700,000 |
| Net Long Term Debt Issuance | $-34,800,000 | $-437,800,000 | $-30,200,000 | $616,700,000 |
| Long Term Debt Payments | $-34,800,000 | $-1,529,000,000 | $-325,300,000 | $-970,600,000 |
| Long Term Debt Issuance | $0 | $1,091,200,000 | $295,100,000 | $1,587,300,000 |
| Net Investment Purchase And Sale | $0 | $-48,200,000 | $0 | $61,700,000 |
| Purchase Of Investment | $0 | $-48,200,000 | $0 | - |
| Net Business Purchase And Sale | $14,400,000 | $215,500,000 | $0 | $-1,952,700,000 |
| Sale Of Business | $14,400,000 | $215,500,000 | $0 | $58,700,000 |
| Net Intangibles Purchase And Sale | $5,600,000 | $5,200,000 | $19,800,000 | $3,300,000 |
| Sale Of Intangibles | $5,600,000 | $5,200,000 | $19,800,000 | $3,300,000 |
| Net PPE Purchase And Sale | $-93,400,000 | $-118,300,000 | $-101,700,000 | $-96,400,000 |
| Purchase Of PPE | $-93,400,000 | $-118,300,000 | $-101,700,000 | $-96,400,000 |
| Change In Working Capital | $-101,100,000 | $-74,700,000 | $-58,500,000 | $20,000,000 |
| Change In Other Current Liabilities | $-200,000 | $0 | $7,600,000 | - |
| Change In Payables And Accrued Expense | $-78,900,000 | $-98,900,000 | $-101,800,000 | $35,500,000 |
| Change In Accrued Expense | $-106,100,000 | $-121,300,000 | $-23,000,000 | $-16,900,000 |
| Change In Payable | $27,200,000 | $22,400,000 | $-78,800,000 | $52,400,000 |
| Change In Account Payable | $-28,700,000 | $54,200,000 | $-65,900,000 | $100,300,000 |
| Change In Tax Payable | $55,900,000 | $-31,800,000 | $-12,900,000 | $-47,900,000 |
| Change In Income Tax Payable | $55,900,000 | $-31,800,000 | $-12,900,000 | $-47,900,000 |
| Change In Prepaid Assets | $8,400,000 | $20,100,000 | $47,500,000 | $25,900,000 |
| Change In Inventory | $-61,100,000 | $13,700,000 | $19,400,000 | $-76,700,000 |
| Change In Receivables | $30,700,000 | $-11,100,000 | $-57,100,000 | $100,000 |
| Changes In Account Receivables | $30,700,000 | $-11,100,000 | $-57,100,000 | $100,000 |
| Other Non Cash Items | $82,800,000 | $109,400,000 | $67,400,000 | $49,400,000 |
| Stock Based Compensation | $54,600,000 | $64,400,000 | $68,800,000 | $54,900,000 |
| Asset Impairment Charge | $1,363,100,000 | $88,900,000 | $90,000,000 | $0 |
| Amortization Of Securities | $-23,800,000 | $-10,100,000 | $1,700,000 | - |
| Deferred Tax | $-50,800,000 | $9,800,000 | $-106,600,000 | $-50,500,000 |
| Deferred Income Tax | $-50,800,000 | $9,800,000 | $-106,600,000 | $-50,500,000 |
| Depreciation Amortization Depletion | $337,500,000 | $325,900,000 | $359,500,000 | $338,600,000 |
| Depreciation And Amortization | $337,500,000 | $325,900,000 | $359,500,000 | $338,600,000 |
| Gain Loss On Sale Of Business | $1,600,000 | $-6,400,000 | $0 | $1,400,000 |
| Net Income From Continuing Operations | $-1,425,400,000 | $-171,800,000 | $-12,700,000 | $-140,600,000 |
| Purchase Of Business | - | $0 | $0 | $-2,011,400,000 |
| Change In Other Working Capital | - | $1,500,000 | $25,900,000 | $35,200,000 |
| Gain Loss On Investment Securities | - | $55,600,000 | - | - |
| Net Foreign Currency Exchange Gain Loss | - | $0 | $0 | $39,400,000 |
| Sale Of Investment | - | - | $0 | $61,700,000 |
| Common Stock Payments | - | - | - | $0 |
| Net Short Term Debt Issuance | - | - | - | $-11,700,000 |
Fetched: 2026-06-17